NeuroPASSBeyond's analysis on NeuroPASS2026-10-07 — CraniUS Therapeutics secures rapid FDA 510(k) clearance and a U.S. patent for its NeuroPASS cranial drug‑delivery systemRecent news mentioning NeuroPASS2026-10-07 — CraniUS Therapeutics Secures Second FDA 510(k) Clearance in Six Weeks and Earns U.S. Patent for NeuroPASS™ 3 Cranial Drug Delivery SystemAppears alongsideCraniUSFDABrowse the full archive →